IACT

Cannabis Market Flourishes Amid Global Legalization, Driving Concerns About Road Safety

Retrieved on: 
Lundi, avril 22, 2024

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Over the past decade, the cannabis market has undergone significant expansion, driven largely by a wave of legalization efforts across the United States and other parts of the world. As state and national governments reassess their legal stance on cannabis, both for medical and recreational use, the industry has seen a surge in legitimacy and economic interest. In the United States, a majority of states have legalized cannabis in some form, reflecting a shift in public opinion and an acknowledgement of the potential medical benefits and revenue generation opportunities. Globally, countries like Canada, Uruguay, and several European nations have moved towards more liberal cannabis policies, further propelling the market's growth. The financial implications of these legalization efforts are substantial and continue to evolve. According to a report by Grand View Research, the global legal cannabis market size was valued at USD 13.2 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 25.5% from 2022 to 2030. Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Cronos Group Inc. (NASDAQ: CRON), Canopy Growth Corporation (NASDAQ: CGC), Aurora Cannabis Inc. (NASDAQ: ACB), Curaleaf Holdings, Inc. (OTC: CURLF)

Key Points: 
  • Globally, countries like Canada, Uruguay, and several European nations have moved towards more liberal cannabis policies, further propelling the market's growth.
  • One of the primary concerns is the correlation between cannabis use and impaired driving.
  • Studies have shown that cannabis can significantly impair motor coordination, reaction times, and decision making, which are critical skills for safe driving.
  • NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic and global markets.

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California

Retrieved on: 
Lundi, avril 22, 2024

VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April.

Key Points: 
  • VANCOUVER, British Columbia, April 22, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be presenting at the International Association for Chemical Testing (IACT) conference in April.
  • Cannabix’s Dr. Bruce Goldberger Ph.D., will be presenting on Science & Technology Behind Cannabis Breath Testing and the Company’s marijuana breathalyzer system at the conference workshop session.
  • IACT is composed of governmental agency personnel involved in chemical testing related to traffic safety.
  • IACT has standing committees to address various areas including legislation, training, new equipment and procedures and manufacturers of breath testing equipment.

Mackenzie Scott Donates $1.5 Million to iACT

Retrieved on: 
Mardi, février 27, 2024

LOS ANGELES, Feb. 27, 2024 /PRNewswire/ -- Mackenzie Scott's Yield Giving has donated $1.5 million to iACT, an award-winning international nonprofit organization.

Key Points: 
  • LOS ANGELES, Feb. 27, 2024 /PRNewswire/ -- Mackenzie Scott's Yield Giving has donated $1.5 million to iACT, an award-winning international nonprofit organization.
  • Mackenzie Scott's innovative approach to philanthropy, investment without restrictions, is unique for iACT in that it creates an opportunity for strengthening our infrastructure, and with that, the ability to reach more children and families.
  • We are proud to receive recognition and support from Mackenzie Scott for how we do our work in partnership with refugee and conflict-affected people.
  • Mackenzie Scott's unrestricted support enables us to dream big with the people and communities we work next to.

ComEd, Millennium Garages Announce Plans For 300 EV Chargers by 2026, Expanding Midwest's Largest Public EV Charging Hub

Retrieved on: 
Mardi, octobre 3, 2023

This expansive EV charging hub is made possible through technical and operational support from ComEd, Civic Infrastructure Collaborative, SP+ Corporation, and multiple EV charging partners.

Key Points: 
  • This expansive EV charging hub is made possible through technical and operational support from ComEd, Civic Infrastructure Collaborative, SP+ Corporation, and multiple EV charging partners.
  • With 100 level-2 EV chargers , Millennium is already the region’s largest public EV charging hub, and it plans to triple EV charging capacity by 2026.
  • All EV charging at Millennium Garages will be powered by certified renewable wind energy.
  • "As we work towards a cleaner, healthier future, we are encouraged to see the expansion of the Midwest's largest public EV charging hub.

Cannabix Technologies to Present at International Association for Chemical Testing (IACT) Conference in Arizona

Retrieved on: 
Mardi, avril 12, 2022

Cannabixs Dr. Jared Boock Ph.D., will be presenting on THC Breath Testing Technology and Instrumentation and the Companys marijuana breathalyzer technologies at the conference workshop session.

Key Points: 
  • Cannabixs Dr. Jared Boock Ph.D., will be presenting on THC Breath Testing Technology and Instrumentation and the Companys marijuana breathalyzer technologies at the conference workshop session.
  • IACT is composed of various governmental agency personnel involved in chemical testing related to traffic safety.
  • IACT has standing committees to address various areas including legislation, training, new equipment and procedures and manufacturers of breath testing equipment.
  • Broader field testing and clinical testing to establish V4.0 benchmark standards are in development with this new device.